ConductScience.org, home

Paper17823293

Disordered purinergic signaling inhibits pathological angiogenesis in cd39/Entpd1-null mice.

Jackson SW and 7 others. Am J Pathol, 2007. Cited by 87 papers, by iCite.

Cite this record

ConductScience Library. Disordered purinergic signaling inhibits pathological angiogenesis in cd39/Entpd1-null mice. Papers, record 17823293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17823293

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Disordered purinergic signaling inhibits pathological angiogenesis in cd39/Entpd1-null mice.
PubMed
Journal
Am J Pathol
PubMed
Year
2007
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
87
iCite
Relative citation ratio, by iCite
1.8
iCite
Revised in PubMed
2025-05-29
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jackson SWShaun W
2Hoshi TTomokazu
3Wu YYan
4Sun XXiaofeng
5Enjyoji KKeiichi
6Cszimadia EEva
7Sundberg CChristian
8Robson SCSimon C

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, CDMajor topic
ApyraseMajor topic
IntegrinsMajor topic
Neovascularization, PathologicMajor topic
PurinesMajor topic
Animals
Cell Adhesion
Cell Proliferation
Endothelium, Vascular
Gene Deletion
Integrin alphaVbeta3
Melanoma, Experimental
Mice
Mice, Mutant Strains
Neoplasm Transplantation
Protein Kinases
Receptors, Purinergic P2
Signal Transduction

Source PubMed

Download CSV of topics

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
AI45897NIAID NIH HHSUnited StatesP01AI045897PubMed and NIHNIH RePORTER
P01 AI045897NIAID NIH HHSUnited StatesP01AI045897PubMed and NIHNIH RePORTER
HL076540NHLBI NIH HHSUnited StatesP01HL076540PubMed and NIHNIH RePORTER
R01 HL063972NHLBI NIH HHSUnited StatesR01HL063972PubMed and NIHNIH RePORTER
HL63972NHLBI NIH HHSUnited StatesR01HL063972PubMed and NIHNIH RePORTER
P01 HL076540NHLBI NIH HHSUnited StatesP01HL076540PubMed and NIHNIH RePORTER

Download CSV of grants

References30

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110742145Mechanisms of angiogenesis and arteriogenesis.Nat Med2000https://conductscience.org/library/papers/10742145PubMed
212386143Regulation of G protein-coupled receptor signaling by scaffold proteins.Circ Res2002https://conductscience.org/library/papers/12386143PubMed
310766752Distinct antitumor properties of a type IV collagen domain derived from basement membrane.J Biol Chem2000https://conductscience.org/library/papers/10766752PubMed
410955784Targeted antiangiogenic therapy for cancer using Vitaxin: a humanized monoclonal antibody to the integrin alphavbeta3.Clin Cancer Res2000https://conductscience.org/library/papers/10955784PubMed
511001068Angiogenesis in cancer and other diseases.Nature2000https://conductscience.org/library/papers/11001068PubMed
611007955Signaling angiogenesis via p42/p44 MAP kinase and hypoxia.Biochem Pharmacol2000https://conductscience.org/library/papers/11007955PubMed
711071621Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells.Blood2000https://conductscience.org/library/papers/11071621PubMed
811331301An RGD sequence in the P2Y(2) receptor interacts with alpha(V)beta(3) integrins and is required for G(o)-mediated signal transduction.J Cell Biol2001https://conductscience.org/library/papers/11331301PubMed
911748109Disordered cellular migration and angiogenesis in cd39-null mice.Circulation2001https://conductscience.org/library/papers/11748109PubMed
1011786895Integrin indecision.Nat Med2002https://conductscience.org/library/papers/11786895PubMed
1112640026Focal adhesion kinase: the first ten years.J Cell Sci2003https://conductscience.org/library/papers/12640026PubMed
1213680353Integrins in angiogenesis: multitalented molecules in a balancing act.Cell Tissue Res2003https://conductscience.org/library/papers/13680353PubMed
1314722085RanBPM is a phosphoprotein that associates with the plasma membrane and interacts with the integrin LFA-1.J Biol Chem2004https://conductscience.org/library/papers/14722085PubMed
1415161625Adenosine A(2A) receptor activation promotes wound neovascularization by stimulating angiogenesis and vasculogenesis.Am J Pathol2004https://conductscience.org/library/papers/15161625PubMed
157507113A mechanism for divalent cation regulation of beta 3-integrins.J Biol Chem1994https://conductscience.org/library/papers/7507113PubMed
167938164Nomenclature and classification of purinoceptors.Pharmacol Rev1994https://conductscience.org/library/papers/7938164PubMed
178756718Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis.Cell1996https://conductscience.org/library/papers/8756718PubMed
188955160Identification and characterization of CD39/vascular ATP diphosphohydrolase.J Biol Chem1996https://conductscience.org/library/papers/8955160PubMed
199916135Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival.J Clin Invest1999https://conductscience.org/library/papers/9916135PubMed
2010470077Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation.Nat Med1999https://conductscience.org/library/papers/10470077PubMed

See all 30 referencesDownload CSV of references

Cited by62

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 87 citations.

PMIDTitleJournalYearIn PapersSource
42137061Integrating multi-omics, machine learning, and molecular dynamics simulations to identify glutamate metabolism-related biomarkers and drug candidates in rheumatoid arthritis.Front Mol Biosci2026https://conductscience.org/library/papers/42137061PubMed
41575692The purinergic signaling interfaces in breast cancer angiogenesis.Purinergic Signal2026https://conductscience.org/library/papers/41575692PubMed
40534663Insights from Clinical Trials on A2A Adenosine Receptor Antagonists for Cancer Treatment.ACS Pharmacol Transl Sci2025https://conductscience.org/library/papers/40534663PubMed
40303330ATP released by ultrasound targeted microbubble cavitation induces vascular inflammation and improves immune checkpoint blockade efficacy.Theranostics2025https://conductscience.org/library/papers/40303330PubMed
39329710Treg Cell Therapeutic Strategies for Breast Cancer: Holistic to Local Aspects.Cells2024https://conductscience.org/library/papers/39329710PubMed
38461171Platelets induce CD39 expression in tumor cells to facilitate tumor metastasis.Br J Cancer2024https://conductscience.org/library/papers/38461171PubMed
38263981Unlocking antitumor immunity with adenosine receptor blockers.Cancer Drug Resist2023https://conductscience.org/library/papers/38263981PubMed
37894719NTPDase1/CD39 Ectonucleotidase Is Necessary for Normal Arterial Diameter Adaptation to Flow.Int J Mol Sci2023https://conductscience.org/library/papers/37894719PubMed
36829496Targets of Immune Escape Mechanisms in Cancer: Basis for Development and Evolution of Cancer Immune Checkpoint Inhibitors.Biology (Basel)2023https://conductscience.org/library/papers/36829496PubMed
36671461Proteomics of High-Grade Serous Ovarian Cancer Models Identifies Cancer-Associated Fibroblast Markers Associated with Clinical Outcomes.Biomolecules2022https://conductscience.org/library/papers/36671461PubMed
35775486Glycoengineered anti-CD39 promotes anticancer responses by depleting suppressive cells and inhibiting angiogenesis in tumor models.J Clin Invest2022https://conductscience.org/library/papers/35775486PubMed
35738682ATP and Adenosine Metabolism in Cancer: Exploitation for Therapeutic Gain.Pharmacol Rev2022https://conductscience.org/library/papers/35738682PubMed
35386701Adenosine-A2A Receptor Pathway in Cancer Immunotherapy.Front Immunol2022https://conductscience.org/library/papers/35386701PubMed
34442398Breast Cancer Cell-Derived Adenosine Enhances Generation and Suppressor Function of Human Adaptive Regulatory T Cells.J Pers Med2021https://conductscience.org/library/papers/34442398PubMed
34145990Metabolic regulation in the immune response to cancer.Cancer Commun (Lond)2021https://conductscience.org/library/papers/34145990PubMed
32728220Targeting CD39 in cancer.Nat Rev Immunol2020https://conductscience.org/library/papers/32728220PubMed
32351498CD73's Potential as an Immunotherapy Target in Gastrointestinal Cancers.Front Immunol2020https://conductscience.org/library/papers/32351498PubMed
32098829On the mechanism of anti-CD39 immune checkpoint therapy.J Immunother Cancer2020https://conductscience.org/library/papers/32098829PubMed
31699796Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity.Cancer Discov2019https://conductscience.org/library/papers/31699796PubMed
31244820Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function.Front Immunol2019https://conductscience.org/library/papers/31244820PubMed

See all 62 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ITGAV3685PubTator's text mininghttps://conductscience.org/library/genes/3685

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17823293

GET https://conductscience.org/api/papers/v1/17823293/references?page=2